Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.95% | 5.19% | 1.98% | -2.11% | -3.80% |
| Total Other Revenue | -5.05% | -2.11% | -2.13% | -1.05% | 7.61% |
| Total Revenue | 7.79% | 5.11% | 1.93% | -2.10% | -3.68% |
| Cost of Revenue | 8.25% | 7.19% | 5.61% | 1.01% | -1.25% |
| Gross Profit | 7.60% | 4.27% | 0.46% | -3.34% | -4.64% |
| SG&A Expenses | 12.20% | 8.82% | 7.05% | 5.32% | 1.09% |
| Depreciation & Amortization | -11.36% | -9.33% | -9.84% | -11.30% | -11.64% |
| Other Operating Expenses | 0.00% | 400.00% | 400.00% | -- | -- |
| Total Operating Expenses | 6.69% | 5.65% | 4.10% | 1.14% | -1.43% |
| Operating Income | 12.99% | 2.68% | -7.52% | -16.04% | -13.01% |
| Income Before Tax | -202.33% | -397.19% | -3.85% | 64.47% | 87.40% |
| Income Tax Expenses | 166.27% | 1,214.29% | 768.75% | 244.54% | 195.40% |
| Earnings from Continuing Operations | -188.21% | -460.74% | -425.86% | 10.35% | 77.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 246.15% | 168.75% | 120.00% | 81.82% | -18.18% |
| Net Income | -163.11% | -479.13% | -532.56% | 12.29% | 76.27% |
| EBIT | 12.99% | 2.68% | -7.52% | -16.04% | -13.01% |
| EBITDA | 1.95% | -2.15% | -7.74% | -12.76% | -11.63% |
| EPS Basic | -162.00% | -477.59% | -515.69% | 13.29% | 76.59% |
| Normalized Basic EPS | 620.48% | 1,060.85% | 95.54% | -161.44% | -126.41% |
| EPS Diluted | -161.37% | -478.33% | -528.12% | 13.57% | 76.57% |
| Normalized Diluted EPS | 620.50% | 1,005.06% | 106.38% | -162.48% | -126.69% |
| Average Basic Shares Outstanding | -0.02% | 0.75% | 0.75% | 0.79% | 0.89% |
| Average Diluted Shares Outstanding | 0.08% | 0.56% | 0.38% | 0.26% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
